Please ensure Javascript is enabled for purposes of website accessibility

LabCorp Launches COVID-19 Testing Service to Help Workers Get Back on the Job

By Jim Crumly – Updated May 14, 2020 at 4:19PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Companies will be able to screen their employees for the coronavirus and test them for prior infections with SARS-CoV-2.

On Thursday, diagnostic testing company Laboratory Corporation of America (LH -1.80%) launched a new service for businesses through which it will assess employees' health and test them for  COVID-19  as part of a return-to-work process.

The service can be provided at the employer's site or at LabCorp facilities. The screening process involves the completion of a questionnaire and a non-invasive temperature check to identify individuals with possible COVID-19 symptoms. The employer can also authorize a polymerase chain reaction (PCR) test, the nasal swab test that reveals currently active cases of COVID-19. Test samples can be collected on-site by LabCorp staff, or the employee can be provided with an at-home collection kit.

Man holding a briefcase and a face mask.

Image source: Getty Images.

LabCorp's service can also include a blood antibody test, which detects the presence of the IgG antibody to SARS-CoV-2, which reveals whether a person has been exposed to the coronavirus and has had an immune response -- whether their case was symptomatic or not. The company announced it would be using a new fingerstick antibody test based on the Euroimmune platform made by Perkin Elmer. The fingerstick, or dried blood spot, antibody test is a convenient testing method that was authorized by the FDA on May 5. The test can be performed at the employer's site, with results available in 2 to 4 days. Scientists don't yet know if a positive antibody test means that a person is immune to reinfection with COVID-19.

LabCorp was the first commercial testing lab in the U.S. to launch a COVID-19 PCR test in early March, and has been ramping up test production in order to meet the large unmet need for coronavirus testing as parts of the U.S. economy begin to reopen.

Jim Crumly has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Laboratory Corporation of America Holdings Stock Quote
Laboratory Corporation of America Holdings
$206.64 (-1.80%) $-3.79
PerkinElmer, Inc. Stock Quote
PerkinElmer, Inc.
$118.07 (-2.08%) $-2.51

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.